October 16 2020 3:31pm

Coronavirus: WHO says Remdesivir not effective in preventing death from COVID-19, trial to assess other antibodies

The World Health Organization Director-General Tedros Adhanom Ghebreyesus said on Friday that WHO’s COVID-19 solidarity trial found Gilead Science’s Remdesivir had no impact on survival rates, adding that it would assess monoclonal antibodies and other antiviral drugs in its trial of potential COVID-19 treatments.

Responsive site?

Video Home